An Amazing Product Producing Amazing Results

 A friend recommended Leimo to me. He has been using it for a year and half now. I could see that his hair is becoming better and better every month since he started using Leimo so I didn’t think twice about placing my order for the free trial. I’m a 36-year-old family man who has been losing hair for 2 years now. Leimo is the first thing I’ve ever tried. And guess what? My hair stopped coming off in excess in just a month, to think my friend didn’t get the same results within his free trial period! Leimo really impressed me a lot!
 

It contains natural ingredients like saw palmetto extracts, mistletoe, and fennel which I’ve heard are very good at preventing further hair loss.     
 

When I first used the Bio-Cleansing Shampoo, Thickening Conditioner, Scalp Therapy, Scalp Serum, and Scalp Scrub altogether almost every day, I thought it very tedious and vain but I didn’t let it get in the way of my treatment. It’s been officially 8 months since I started using Leimo. I admit the habit does not become easy at all. But I never regretted anything. In fact, everything seems to be paying off—after all that hard work and constant reminding.
 

The products smelled very good. Also, the consistency was neither too thick nor thin. More than that, altogether, they made my hair softer and I also stopped accumulating dandruff. My scalp is no longer that flaky.
 

 It’s an amazing product, definitely, a must-have for those who are starting to lose their hairs. Don’t wait for 2 years before it gets worse and harder to treat. You can visit their site and order for your free trial. You can also learn about the rest of their products, specifically the Personal Hair Laser.

Visit http://www.leimo-hairloss.co.uk for more information

Best Tricks to prevent Hair Loss

Have problems on hair loss? Looking for the right hair loss treatment? Don’t let your hair let you down! Hair loss is a condition caused by a lot of factors. It can be from pregnancy, lack of minerals, too much stress and even bad genetics. But fear not for there are already ways on how to prevent hair loss.

If you are serious about preventing your hair loss and letting those locks grow back better than they ever did before, it is important you take the advice you receive and prevent further hair loss. It is much easier to stop the hair loss than it is to grow new hair back.

The following are simple techniques on how to prevent hair loss:
1. Drink 7 to 10 glasses of water daily to keep your body hydrated and your hair healthy.
2. Since protein makes up most of our hair, it is important to have enough protein in our diet. Stick to fish, chicken, eggs and yogurt. Pork and beef contain too much fat which will only induce hair loss.
3. The same goes for calcium-rich foods. This mineral also helps in keeping the scalp and hair healthy.

Another simple way how to prevent hair loss is to avoid activities that will dry up or damage hair like curling, dyeing, blow drying, and tight hairstyles.

There are already available hair growing products in the market. But a lot of these are not really proven to be safe and effective. However there is an available over the counter medication that is proven to be safe and effective. Minoxidil, also known as Rogaine, has been shown to be effective. It comes in 3 concentrations; 2%, 4% and 5%. Minoxidil should be applied at least twice a day into the desired area. But application in other areas should be avoided because it may also grow hair.

'Magic Bullet' Drug Delays Breast Cancer Worsening

June 4, 2012 (Chicago) -- A new targeted cancer drug delayed the worsening of metastatic breast cancer, possibly with fewer side effects than traditional treatments, according to results of a late-stage study.

Called T-DM1, the new drug combines Herceptin with a potent chemotherapy drug. It's been called a "magic bullet": Herceptin homes in on cancer cells and delivers the cancer-killing agent directly to its target without damaging nearby cells.

The study involved nearly 1,000 women with metastatic breast cancer that was continuing to get worse despite treatment with Herceptin and a common chemotherapy drug.

Half the women got T-DM1 and the other half got Tykerb and Xeloda, a standard treatment for women who aren't helped by Herceptin.

T-DM1 delayed the time to the disease progressing by about three months. Among women who received T-DM1, the average time before the disease got worse was about nine-and-a-half months vs. about six-and-a-half months for those getting the standard drugs.

Although a few months might not sound like much, it can be a huge gain for seriously ill patients who are running out of options, say doctors studying the drug.

It is still too early to know for sure that T-DM1 will prolong lives, but the early data suggest that it will, says researcher Kimberly Blackwell, MD, of Duke University.

For the most part, women taking T-DM1 did not suffer the often debilitating side effects associated with chemotherapy, such as diarrhea, nausea, vomiting, and hair loss, she tells WebMD.

Still, the drug is not without toxicity: About 41% of women on T-DM1 suffered a serious side effect vs. 57% of those getting standard treatment.

About 13% of women getting T-DM1 had lowered blood platelet counts, which can increase the risk of bleeding. But there were very few cases of bleeding.

The findings were presented here at the annual meeting of the American Society of Clinical Oncology.

How T-DM1 Works

About 20% of breast cancer patients have an aggressive form of the disease known as HER2-positive tumors. Herceptin, a man-made antibody, binds to and blocks part of the HER2 protein that appears on the surface of some breast cancer cells. It revolutionized the way this type of tumor was treated when it was approved in the late 1990s.

But many metastatic breast cancers eventually become resistant to Herceptin. So researchers have been searching for new drugs that target HER2.

T-DM1 is such a drug. The "T" stands for trastuzumab, the scientific name for Herceptin. The DM1 is derived from an old chemotherapy drug called maytansine that was abandoned several decades ago when it was found to be too toxic for patients.

Because Herceptin only zeroes in on cancer cells that express HER2, DM1 is delivered only to those cells, Blackwell says.